肿瘤坏死因子相关蛋白9抑制核因子κB核转位对巨噬细胞炎症因子表达的影响被引量：6

C1q/ tumor necrosis factor-related protein 9 decreases pro-inflammatory cytokines expression in macrophage cells by inhibiting nuclear factor-κB translocation

原文传递

导出

摘要目的探究肿瘤坏死因子相关蛋白9（CTRP9）对氧化型低密度脂蛋白（ox-LDL）诱导RAW 264.7小鼠巨噬细胞抗炎作用和机制. 方法选择RAW264.7小鼠巨噬细胞系,分为对照组（对照组）、oxLDL组、gCTRP9＋ oxLDL组.采用油红O染色鉴定泡沫细胞,免疫印迹分析检测肿瘤坏死因子（TNF）-α、单核细胞趋化蛋白（MCP-1）及胞浆、细胞核核转录因子κB （NF-κB） p65蛋白表达水平. 结果与对照组比较,ox-LDL组巨噬泡沫细胞中MCP-1蛋白和TNF-α蛋白表达上调（P＜0.05）,与ox-LDL组比较,gCTRP9＋ oxLDL组TNF-α和MCP-1的蛋白表达降低（P＜0.05）.oxLDL组与对照组比较,NF-κB表达增加（P＜0.05）;与ox-LDL组比较,gCTRP9组2h和8hNFκB P65表达下降,1.03±0.06比0.17±0.10和0.31±0.03（均P＜0.05）. 结论 oxLDL可诱导巨噬细胞表达TNF-α和MCP-1,gCTRP9可减少oxLDL的促炎作用,NF-κB信号转导通路可能参与了上述抗炎作用机制,提示gCTRP9可能具有抗炎,抗动脉粥样硬化的保护性作用. Objective To investigate the anti-inflammatory effect of C1q/ tumor necrosis factor （TNF）-related protein 9 （CTRP9） in RAW264.7 mouse macrophage cells treated with oxidized low density lipoprotein （oxLDL）,and to explore its mechanism.Methods RAW264.7 mouse macrophage cells were divided into three groups：the control group,the oxLDL group （treated with oxLDl） and the gCTRP9-oxLDL group （pretreated with recombinant globular domain of CTRP9 and stimulated by oxLDL）.Foam cells were detected by oil red O staining.Western blot was used to detect the expressions of pro-inflammatory cytokines tumor necrosis factor-α （TNF-α） and monocyte chemoattractant protein 1 （MCP-1）.In addition,the expression levels of NF-κB p65 in cytoplasm and nucleus proteins extraction were both determined.Results The relative levels of MCP-1 and NF-κB were increased in the oxLDL group as compared with the control group （1.66±0.09 vs.1.03±0.10,0.52±0.11 vs.1.03±0.06,both P〈0.05）.The expression levels of TNF-α and MCP-1 were decreased in gCTRP9＋oxLDL group as compared with the oxLDL group （both P〈0.05）.The expression level of NF κB p65 in nucleus 2 and 8 h after treatment was lower in the gCTRP9＋oxLDL group than in the oxLDL group （1.03±0.06 vs.0.17±0.10,0.31±0.03,both P〈0.05）.Conclusions oxLDL may induce the expressions of inflammatory cytokines of TNF α and MCP-1 in macrophage ceils.gCTRP9 pretreatment could reduce the oxLDL-induced pro inflammatory effect and nuclear factor κB translocation may be involved in this process,which suggests that gCTRP9 may play a protective role in anti inflammatory and anti-atherosclerosis.

作者李俊李婷婷张鹏刘天骄黄承敏高海青郭媛

机构地区山东大学齐鲁医院心内科

出处《中华老年医学杂志》 CAS CSCD 北大核心 2015年第6期664-666,共3页 Chinese Journal of Geriatrics

基金国家自然科学基金（NSFC：81350025）

关键词肿瘤坏死因子动脉粥样硬化 Tumor necrosis factor Atherosclerosis

分类号 R543.5 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献10

1Hansson GK, Hermansson A. The immune system in atherosclerosis[J]. Nat Immunol, 2011. 12: 20.'1-212.
2Intimal R, Dcalactti A, Galkina E, et al. I.eukocyte influx in atheroselerosis [J] . Curr Drug Targets, 2007, 8: 1239-1248.
3Moore K J, Tabas I. Macrophages in the pathogenesis of atherosclerosis[J]. Cell, 2011, 145; 341 355.
4李明春,陆林,陈秋静,张瑞岩,张奇,沈卫峰.血清CTRP9水平与冠心病的关系[J].国际心血管病杂志,2013,40(5):323-325. 被引量：10
5刘天骄,郭媛,李婷婷,张建宁,李俊,张鹏.血清CTRP9、APN水平与急性冠脉综合征的相关性[J].山东大学学报（医学版）,2014,52(9):58-62. 被引量：8
6ZhengQ, Yuan Y, Yi W. et al. Clq/TNF related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor 1/AMPK/eN()S/nitric oxide signaling pathway[J]. Arterioscler Thromh Vasc Biol, 2011, 31 : 2616-2623.
7mmra Y. Shibata R, ()hashi K, et al. Adipose- derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation[J3. FASEB J. 2013, 27:25 33.
8Ionizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity[J] Trends Inmmnol, 2004, 25: 280-288.
9Pnkenburg (). Platz J, Beisswenger C, et al. Inhibition of NF kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus[J]. J Virol Methods, 2004. 12: 119-122.
10Yao R. Cheng X, Ghen Y, et al. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol diet apolipoprotein E knock-out mice[J]. Int J Cardiol, 2010, 139:113 122.

二级参考文献29

1Wong GW, Wang J, Hug C, et al. A family of Acrp30/ adiponectin structural and functional paralogs[J]. Proc Natl Acad Sci U S A,2004,101(28) :10302- 10307.
2Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to CIq, produced exclusively in adipocytes [J]. J Biol Chem,1995,270(45) :26746-26749.
3Sehfiffler A, Buechler C. CTRP family: linking immunity to metabolism[J]. Trends Endocrinol Metab, 2012, 23 (4): 194-204.
4Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin[J]. FASEB J, 2009, 23(1): 241-258.
5Kambara T, Ohashi K, Shibata R, et al. CTRP9 protects against myocardial injury following isehemia-reperfusion through AMPK-dependent mechanism [J]. J Biol Chem, 2012, 287(23) : 18965-18973.
6Su H, Yuan Y, Wang XM,et al. Inhibition of CTRP 9, a novel and cardiac-abundantly expressed cell survival molecule by TNF-alpha-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice [J]. Basic Res Cardiol, 2013, 108(1): 315.
7Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons; endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J]. Circulation, 2007 ,116(7):e148-e304.
8Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee [J]. Circulation, 2008,117 (2) :296-329.
9Fruebis, J, Tsao, "IS, Javorschi, S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss inmiee[J]. Proc Natl Acad Sci U S A, 2001, 98 (4): 2005-2010.
10Berg AH, Combs TP, Du X, et ah The adipocyte-secreted protein Acrp30 enhances hepatic insulin action[J]. Nat Med, 2001,7(8) :947-953.